Use Bond to offset short term systematic risk or to hedge overall market volatility. The stock experiences little momentum. The pattern is not really predictable. Watch out for false signals
1 Month Beta ..........
3.38
As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Bond will likely underperform.
The median price of Bond for the period between Wed, Apr 25, 2012 and Fri, May 25, 2012 is 0.08 with a coefficient of variation of 14.58. The daily time series for the period is distributed with a sample standard deviation of 0.01, arithmetic mean of 0.08, and mean deviation of 0.01. The Stock did not receive any noticable media coverage during the period.
Bond Laboratories Inc. [BNLB] is traded as part of a regulated electronic trading service offered by the NASD. The company currently falls under 'Nano-Cap' category with current market capitalization of 4.53 M. Bond Laboratories Inc. operates under Healthcare sector and is part of Drug Related Products industry. This company has 74.3 M outstanding shares.
Bond Liquidity
BOND LABORATORIE has accumulated about 887.11 K in cash with 495.98 K of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
The company has accumulated 437.09 K in total debt with debt to equity ratio (D/E) of 0.11 which may suggest the company is not taking enough advantage from borrowing. Bond Laboratories Inc. has Current Ratio of 2.11 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.